OTC Markets Group is undervalued with strong customer dependency and earnings growth. Read why OTCM stock is a solid pick due to its competitive advantage.

Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...

OTC Markets Group Inc. (OTCM) came out with quarterly earnings of $0.60 per share, missing the Zacks Consensus Estimate of $0.70 per share. This compares to earnings of $0.58 per share a year ago.

Glenmark Pharmaceuticals launches polyethylene glycol 3350, a constipation treatment medicine in the US. The OTC product aims ...

The outflow of gold stored in the London vaults to the United States slowed in February, the London Bullion Market ...

US leads multiyear record inflows February in review. Global physically backed gold ETFs 1 saw significant inflows in ...

As the future of UK and European capital markets remains uncertain and the debate on London and European markets versus New ...

Glenmark Pharmaceuticals has introduced a new constipation treatment, polyethylene glycol 3350 powder, to the US market. This launch aims to fulfill the rising demand for a fresh supplier in the ...

Shares for Japan-based Metaplanet jumped 21% after the company announced that it bought 156 more Bitcoin valued at $13.4 ...

According to Nielsen® syndicated data for the latest 52 weeks' period ending February 22, 2025, the MiraLAX® Powder for Solution, 17 grams (OTC) market 3 achieved annual sales of approximately $ ...

MAHWAH, N.J., March 10, 2025 /PRNewswire/ -- Glenmark Therapeutics Inc., USA (Glenmark) is pleased to announce the launch1 of Polyethylene Glycol 3350, Powder for Solution, 17 grams/capful (OTC ...